To date, no effective vaccines or therapies are available against the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the causative pandemic agent of the coronavirus …

CoVID‐19 is a multi‐symptomatic disease which has made a global impact due to its ability
to spread rapidly, and its relatively high mortality rate. Beyond the heroic efforts to develop …

Background The incidence of nosocomial infections including ventilator-associated
pneumonia and bacteraemia has been described during the COVID-19 pandemic. However …

Microbial translocation (MT) and intestinal damage (ID) are poorly explored in COVID-19.
Aims were to assess whether alteration of gut permeability and cell integrity characterize …

Abstract Background Coronavirus SARS-CoV-2 causes COVID-19 illness which can
progress to severe pneumonia. Empiric antibacterials are often employed though frequency …

Teicoplanin has a potential antiviral activity expressed against severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) and was suggested as a complementary option to …

Background Immunosuppressive therapies proposed for Coronavirus disease 2019 (COVID-
19) management may predispose to secondary infections. We evaluated the association of …

Background Little is known in distinguishing clinical features and outcomes between
coronavirus disease-19 (COVID-19) and influenza (FLU). Materials/methods Retrospective …

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
pushed the scientific community to undertake intense research efforts. Understanding SARS …

At present, coronavirus disease 2019 (Covid-19), caused by SARS-CoV-2 infection, has
turned into a global pandemic. Comparable to the H7N9 virus, SARS-CoV-2 causes soaring …